ROP — Roche Holding AG Share News
0.000.00%
Last trade - 00:00- CH₣254.44bn
- CH₣276.23bn
- CH₣61.52bn
AstraZeneca obesity pill helps patients lose 10.5% of body weight in trial
Roche enters cancer drug deal worth up to $2.3 billion with Nurix Therapeutics (updated)
Nurix Therapeutics jumps on $2 billion cancer drug agreement with Roche
Roche enters $2 billion cancer drug agreement with Nurix Therapeutics
Press Digest: Wall Street Journal - June 8
Brief: Roche To Collaborate With Nurix Therapeutics On BTK Degrader Bexobrutideg
Roche obesity drug helps patients shed 22.7% of weight in mid-stage trial
Brief: Zealand Pharma Says Phase 2 Zupreme-1 Trial Met Its Primary Endpoint
Zealand touts promising tolerability data for obesity drug in mid-stage study
Swiss stocks - Factors to watch on June 5
Brief: Roche Develops PCR Test For Ebola Bundibugyo Virus
Roche chairman likens US tariff policy to 'blackmail' (updated)
Roche chairman flags concern over U.S., China protectionism
ADC Therapeutics plunges after patient deaths in blood cancer drug trial
ADC Therapeutics falls on higher rates of serious side-effects in cancer trial
Brief: IDEAYA Biosciences Announces Clinical Collaboration With Roche In Mtap-Deleted Ras-Mutant Pancreatic Cancer
'It's still working': More are living with cancer as era of targeted drugs takes hold
Table: Swiss trade surplus at CHF 3.098 bln in April
Brief: FDA Accepts NDA For Roche's Giredestrant In ER-Positive Early-Stage Breast Cancer